These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 10908002

  • 1. The CSAT methamphetamine treatment program: research design accommodations for "real world" application.
    Huber A, Lord RH, Gulati V, Marinelli-Casey P, Rawson R, Ling W.
    J Psychoactive Drugs; 2000; 32(2):149-56. PubMed ID: 10908002
    [Abstract] [Full Text] [Related]

  • 2. A multisite study of the effectiveness of methamphetamine treatment: an initiative of the Center for Substance Abuse Treatment.
    Herrell JM, Taylor JA, Gallagher C, Dawud-Noursi S.
    J Psychoactive Drugs; 2000; 32(2):143-7. PubMed ID: 10908001
    [Abstract] [Full Text] [Related]

  • 3. A descriptive analysis of participant characteristics and patterns of substance use in the CSAT methamphetamine treatment project: the first six months.
    Reiber C, Galloway G, Cohen J, Hsu JC, Lord RH.
    J Psychoactive Drugs; 2000; 32(2):183-91. PubMed ID: 10908006
    [Abstract] [Full Text] [Related]

  • 4. Methamphetamine abuse: issues for special populations.
    Freese TE, Obert J, Dickow A, Cohen J, Lord RH.
    J Psychoactive Drugs; 2000; 32(2):177-82. PubMed ID: 10908005
    [Abstract] [Full Text] [Related]

  • 5. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
    Rawson RA, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, Galloway GP, Herrell J, Huber A, McCann MJ, Obert J, Pennell S, Reiber C, Vandersloot D, Zweben J, Methamphetamine Treatment Project Corporate Authors.
    Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
    [Abstract] [Full Text] [Related]

  • 6. When treatment meets research: clinical perspectives from the CSAT Methamphetamine Treatment Project.
    Obert JL, Brown AH, Zweben J, Christian D, Delmhorst J, Minsky S, Morrisey P, Vandersloot D, Weiner A.
    J Subst Abuse Treat; 2005 Apr; 28(3):231-7. PubMed ID: 15857723
    [Abstract] [Full Text] [Related]

  • 7. Moving research into community settings in the CSAT methamphetamine treatment project: the coordinating center perspective.
    Rawson RA, McCann MJ, Huber A, Marinelli-Casey P, Williams L.
    J Psychoactive Drugs; 2000 Apr; 32(2):201-8. PubMed ID: 10908008
    [Abstract] [Full Text] [Related]

  • 8. Treatment-as-usual in the methamphetamine treatment project.
    Galloway GP, Marinelli-Casey P, Stalcup J, Lord R, Christian D, Cohen J, Reiber C, Vandersloot D.
    J Psychoactive Drugs; 2000 Apr; 32(2):165-75. PubMed ID: 10908004
    [Abstract] [Full Text] [Related]

  • 9. Conducting trials in community settings: the provider perspective.
    Zweben JE, Cohen JB, Obert J, Vandersloot D, Marinelli-Casey P.
    J Psychoactive Drugs; 2000 Apr; 32(2):193-9. PubMed ID: 10908007
    [Abstract] [Full Text] [Related]

  • 10. The CSAT methamphetamine treatment project: what are we trying to accomplish?
    Anglin MD, Rawson RA.
    J Psychoactive Drugs; 2000 Apr; 32(2):209-10. PubMed ID: 10908009
    [No Abstract] [Full Text] [Related]

  • 11. The matrix model of outpatient stimulant abuse treatment: history and description.
    Obert JL, McCann MJ, Marinelli-Casey P, Weiner A, Minsky S, Brethen P, Rawson R.
    J Psychoactive Drugs; 2000 Apr; 32(2):157-64. PubMed ID: 10908003
    [Abstract] [Full Text] [Related]

  • 12. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R.
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [Abstract] [Full Text] [Related]

  • 13. Integrating research and practice in the CSAT Methamphetamine Treatment Project.
    Hamilton Brown A.
    J Subst Abuse Treat; 2004 Mar; 26(2):103-8. PubMed ID: 15050087
    [Abstract] [Full Text] [Related]

  • 14. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.
    Shoptaw S, Reback CJ, Peck JA, Yang X, Rotheram-Fuller E, Larkins S, Veniegas RC, Freese TE, Hucks-Ortiz C.
    Drug Alcohol Depend; 2005 May 09; 78(2):125-34. PubMed ID: 15845315
    [Abstract] [Full Text] [Related]

  • 15. Methamphetamine users entering treatment: characteristics of the methamphetamine treatment project sample.
    Christian DR, Huber A, Brecht ML, McCann MJ, Marinelli-Casey P, Lord RH, Reiber C, Lu TH, Methamphetamine Treatment Project, Galloway GP.
    Subst Use Misuse; 2007 May 09; 42(14):2207-22. PubMed ID: 18098001
    [Abstract] [Full Text] [Related]

  • 16. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A, Shepard D, Horgan C, Ritter G.
    J Ment Health Policy Econ; 2007 Mar 09; 10(1):3-13. PubMed ID: 17417043
    [Abstract] [Full Text] [Related]

  • 17. Cooperative agreement with Policy Research, Inc., to continue the National GAINS Center for People with Co-Occurring Disorders in the Justice System. Center for Substance Abuse Treatment (CSAT) and Center for Mental Health Services (CMHS), Substance Abuse and Mental Health Services Administration (SAMHSA), HHS.
    Fed Regist; 1999 Apr 22; 64(77):19799. PubMed ID: 10558478
    [Abstract] [Full Text] [Related]

  • 18. Grant award to the Division of Mental Health and Developmental Disabilities, Department of Health and Social Services, State of Alaska. Center for Substance Abuse Treatment (CSAT), Center for Mental Health Services (CMHS), Substance Abuse and Mental Health Services Administration (SAMHSA), HHS. Availability of grant funds for the Division of Mental Health and Developmental Disabilities, Department of Health and Social Services, State of Alaska.
    Fed Regist; 1999 Apr 16; 64(73):18922-3. PubMed ID: 10558551
    [Abstract] [Full Text] [Related]

  • 19. A comparison of injecting and noninjecting methamphetamine users.
    Domier CP, Simon SL, Rawson RA, Huber A, Ling W.
    J Psychoactive Drugs; 2000 Apr 16; 32(2):229-32. PubMed ID: 10908012
    [Abstract] [Full Text] [Related]

  • 20. History of the methamphetamine problem.
    Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S.
    J Psychoactive Drugs; 2000 Apr 16; 32(2):137-41. PubMed ID: 10908000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.